Table 3 Participant Characteristics at baseline [53]

Age (Years), Mean (SD)

45 (9.4)

41.5 (8.2)

Female/Male

7/7

8/8

Height (cm), Mean (SD)

173 (8.7)

176 (9.5)

Weight (kg), Mean (SD)

76 (10.7)

80 (15.8)

BMI, MEAN (SD)

25.4 (3.3)

25.9 (5.1)

Side of injury (L/R)

7/7

10/6

Duration of Symptoms (months)

14 (16.2)

10 (7.2)

Flouroquinolone antibiotics (Y/N)

0/14

0/16

Corticosteroids (Y/N)

0/14

2/14

Anti-inflammatory medication (Y/N)

4/10

6/10

Statin medication (Y/N)

0/14

0/16

Diabetes medication (Y/N)

0/14

0/16

Allopurinol medication (Y/N)

0/14

0/16

Aromatrose inhibitors

0/14

0/16

Physical Activity Levels (active/inactive)

14/0

12/4

International Physical Activity Questionnaire (High/Moderate/Low)

7/7/0

6/9/1

Presence of comorbidities (Y/N)

1/13

1/15

Inflammatory or rheumatoid arthritis (Y/N)

0/14

0/16

Psoriasis (Y/N)

1/13

1/15

Inflammatory bowel or eye disease (Y/N)

0/14

0/16

Ankylosing spondylitis (Y/N)

0/14

0/16

Gout (Y/N)

0/14

0/16

Diabetes 1 or 2/ impaired glucose sensitivity (N)

0/14

0/16

Hypertension or cardiac disease (Y/N)

1/13

1/15

Hypertriglyceridemia/ high cholesterol (Y/N)

2/12

0/16

Familial hypercholesterolemia (Y/N)

5/9

8/8

Collagen disorders (Y/N)

0/14

0/16

Fibromyalgia (Y/N)

0/14

0/16

Imaging (N/MRI/US)

11/2/1

16/0/0

Prior History of Tendinopathy (N/Achilles/Patellar)

9/4/1

10/5/1